Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol mebutate versus diclofenac for actinic keratosis of the face or scalp
2014-003218-98Phase 4Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of ingenol mebutate and diclofenac in actinic keratosis (AK) (2 arms), sponsored by LEO Pharma. Primary endpoint: Complete clearance of all actinic keratoses in the treatment field. Started Dec 2014; status: completed.
02
Drugs
ingenol mebutatediclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2014-003218-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003218-98.